The Changes of Natural Killer Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B.
Phase of Trial: Phase IV
Latest Information Update: 15 Jul 2017
At a glance
- Drugs Ropeginterferon alfa-2b (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 10 Jul 2017 New trial record